2353 results about "Pyrazole" patented technology

The invention provides a nitrification inhibitor and a preparation method thereof as well as stable urea and a preparation method thereof, and relates to the technical field of fertilizers. The nitrification inhibitor provided by the invention is prepared from the following components in percentage by mass: 20 to 45 percent of 3, 4-dimethyl pyrazole phosphate (DMPP), 30 to 70 percent of amino acid and the balance of auxiliaries, the auxiliary agent is one or more of polysaccharide, polyvinylpyrrolidone, poloxamer and carbomer. According to the invention, the DMPP and the amino acid are compounded, the amino acid is used as a stabilizer of the DMPP, so that the stability of the DMPP can be remarkably improved, and meanwhile, the polymer additive is used as an adhesive, so that the stability of the DMPP can be further improved. The nitrification inhibitor provided by the invention has excellent stability; the stable urea can be obtained by adopting an endogenous adding mode and adding the stable urea into the urea with relatively low loss, and the stable urea has multiple effects of improving the urea utilization rate, improving the crop quality, improving the soil biological environment, improving the soil fertility and the like.

The invention discloses a preparation method of a pyrazolone amino-acid ester derivative. The pyrazolone amino-acid ester derivative is obtained through three-component cascade reaction by taking pyrazolone imine, a pentafluorophenylacetate derivative and alcohol as reactants and chiral isothiourea as a catalyst. According to the invention, challenges of competitive side reactions between a plurality of reaction substrates and intermediates and stereoselectivity control are overcome, the application range of the substrate combination of the existing system is broken through, and synthesis of a series of pyrazolone amino-acid ester derivatives is realized in a green and efficient manner. According to the method disclosed by the invention, substrate preassembly is not needed, transition metal catalysis is not needed, raw materials and the catalyst are cheap and easy to obtain, reaction conditions are mild, and the substrate application range is wide. In addition, the invention also provides a new way for introducing the medicine bioactive molecules into the synthesis of the pyrazolone amino-acid ester compound.

The invention relates to the technical field of pesticide production, in particular to a synthesis method of 1-methyl-3-trifluoromethyl-4-chloromethyl-5-difluoromethoxy-1-H-pyrazole, which at least comprises the following steps: firstly, mixing trioxymethylene and 1-methyl-3-trifluoromethyl-5-difluoromethoxy-1-H-pyrazole to prepare a solution A; the solution A and chlorosulfonic acid are mixed and then subjected to a chloromethylation reaction, 1-methyl-3-trifluoromethyl-4-chloromethyl-5-difluoromethoxy-1-H-pyrazole is obtained through aftertreatment after sampling detection is qualified, and the method is high in product yield, high in purity, low in production cost, high in production efficiency, easy to operate, capable of meeting the green and environment-friendly requirements and suitable for industrial production. The industrial production is easy to realize.

The invention provides a pharmaceutical composition containing a pyrazole ether compound and application of the pharmaceutical composition, the pharmaceutical composition comprises an effective component A and an effective component B. The effective component A is a pyrazole ether compound with a structure shown in a formula I; and the effective component B is selected from any one or a combination of at least two of azole bactericides, mitochondrial electron transport chain compound III inhibitor bactericides, SDHI bactericides, multi-site contact type bactericides or other bactericides. In the invention, the effective component A and the effective component B have a synergistic effect, so that the pharmaceutical composition has higher biological activity and favorable or wider active spectrum, can reduce the application amount of compounds and compositions required for effectively controlling phytopathogens, and has longer lasting activity.

This invention relates to a crystalline 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I),and compositions thereof. Also disclosed herein are methods of making the same and methods of using the same.

The invention belongs to the technical field of liquid chromatography-mass spectrometry detection pretreatment, and particularly relates to a pretreatment method for liquid chromatography-tandem mass spectrometry analysis of pesticide and veterinary drug residues in serum, which comprises the following steps: (S1) carrying out heating reaction on Sc (III) salt, Cu (II) salt and 1H-pyrazole-4-formic acid (H2PyC) in a polar aprotic solvent, and cooling to obtain a green crystal, namely MOF-919; the chemical formula of the MOF-919 is [Sc < 3 > (mu3-O) (OH) < 3 >] [Cu3 (mu3-O) (mu-PyC) < 3 > (H2O) < 6 >] < 2 >; (S2) mixing the serum sample with an acetonitrile solution containing formic acid, carrying out ultrasonic treatment, vortex oscillation and centrifugation, taking supernate, and diluting the supernate with an aqueous solution containing formic acid to obtain a to-be-purified solution; and (S3) adding MOF-919 into the to-be-purified liquid, mixing, performing ultrasonic treatment, performing vortex oscillation, centrifuging, and taking supernate, thereby completing the pretreatment of the to-be-purified liquid. According to the method, the MOF-919 is used for adsorbing chemical pollutant residues in serum, especially phospholipids, so that the purpose of removing the chemical pollutant residues in blood is achieved. The method is simple and convenient to operate, small in organic solvent consumption and good in purification effect, and can be widely applied to residue analysis of chemical pollutants in serum.

The disclosure is directed to 4-pyrazolo[1,5-a]pyridin-2-yl-4, 5,6,7- tetrahydro-1H-imidazo[4,5-c]pyridine derivatives of formula (I) and pharmaceutically acceptable salts thereof, that stabilize phenylalanine hydroxylase (PAH) mutations, pharmaceutical compositions comprising those compounds, and methods of using those compounds in methods for stabilizing a mutant PAH protein or reducing blood phenylalanine concentration in a subject suffering from phenylketonuria. In some embodiments, the mutant PAH protein contains at least one R408W, R261Q, R243Q, Y414C, L48S, A403V, I65T, R241C, L348V, R408Q, or V388M mutation. In other embodiments, the mutant PAH protein contains at least one R408W, Y414C, I65T, F39L, R408Q, L348V, R261Q, A300S, or L48S mutation.

The invention relates to a pyrazole fused ring compound as well as a preparation method and application thereof. Specifically, the invention relates to a compound shown in a general formula (I), a preparation method of the compound, a pharmaceutical composition containing the compound and application of the compound serving as an FGFR inhibitor in tumor treatment. Wherein each group in the general formula (I) is defined in the specification. # imgabs0 #

The present disclosure relates to pharmaceutically acceptable salts, cocrystals, and crystalline forms thereof, of a compound which is N—((S)-1-(3-(4-chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2- ((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-TH-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetamide, which is useful in the treatment of a Retroviridae viral infection including an infection caused by the HIV virus.

The invention discloses a selective etching solution for a titanium and / or copper metal layer of a circuit board and a preparation method of the selective etching solution, and the selective etching solution comprises the following components: 10-20% of persulfate, 4-8% of o-nitrobenzenesulfonate, 0.5-1% of phosphoric acid, 0.2-0.8% of 3-(aminomethyl) pyrazole, 0.3-1.5% of ammonium fluoride, 2-5% of cyclohexanediamine tetraacetic acid, 0.1-0.5% of cyclodextrine and the balance of water. The etching solution can selectively etch a titanium and / or copper metal layer, through selection and cooperation of etching solution components, etching is uniform and stable, taper angle and lateral etching control is good, metal wires are smooth, no metal residues exist, and a good etching solution is provided for the circuit board etching process.

The invention provides a 4 (1H-pyrazol-3-yl) piperidinyl derivative, the structural formula of the 4 (1H-pyrazol-3-yl) piperidinyl derivative is shown as a formula I, # imgabs0 #, R1 is an aromatic ring or a substituted aromatic ring, the substituted aromatic ring is a substituent group on the aromatic ring, and R2 is a hydrogen atom or a hydrogen atom or a substituent group on the substituted aromatic ring, so that the structural formula of the 4 (1H-pyrazol-3-yl) piperidinyl derivative is shown as a formula I; the substituent groups are selected from C1-C6 alkyl groups, C1-C6 halogenated alkyl groups, C1-C6 alkylamino groups, C1-C6 alkoxy groups, five-membered to six-membered heterocyclic groups, halogen, hydroxyl groups, cyano groups, nitryl groups, amino groups and carbonyl substituted five-membered to six-membered heterocyclic groups containing 1-2 nitrogen atoms; and R2 is H or a C1-C6 alkyl group. The 4 (1H-pyrazol-3-yl) piperidinyl derivative has MNK1 and / or MNK2 inhibitory activity, and has anti-cancer and anti-inflammatory activity; the invention also provides a preparation method of the 4 (1H-pyrazol-3-yl) piperidinyl derivative, an application of the 4 (1H-pyrazol-3-yl) piperidinyl derivative in preparation of MNK1 and / or MNK2 inhibitors, and an application of the 4 (1H-pyrazol-3-yl) piperidinyl derivative in preparation of anti-inflammatory and anti-cancer drugs.

The invention discloses a pyraclostrobin preparation device which comprises a reaction kettle and further comprises a temperature control cooling box, the temperature control cooling box is provided with a containing space, a partition part is arranged in the temperature control cooling box, the partition part divides the containing space into a cooling channel and a temperature control channel, and the temperature control channel is communicated with the cooling channel. The temperature control cooling box and the separation part are both made of heat conduction materials, a hydrothermal solution is introduced into the temperature control channel, and the temperature of the hydrothermal solution is higher than the crystallization temperature of pyraclostrobin. According to the pyraclostrobin preparation device provided by the invention, the reaction kettle and the temperature control cooling box are combined for use, so that a pyraclostrobin solution can circularly move between the reaction kettle and the temperature control cooling box, and precipitates and irregular crystals are fed into the reaction kettle for re-processing; the production speed of the pyraclostrobin crystals is increased, and meanwhile continuous production can be achieved.

Disclosed is a series of pyrazolopyridine compounds, and application thereof in the preparation of RET kinase inhibitors for treatment. Specifically disclosed is the compound represented by formula (I), or a pharmaceutically acceptable salt thereof.

The invention relates to a preparation method of 3-[(1S, 2S)-1-[5-[(4S)-2, 2-dimethyl oxacyclohexane-4-yl]-2-[(4S)-2-(4-fluoro-3, 5-dimethyl phenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6, 7-dihydro-4H-pyrazolo [4, 3-c] pyridine-5-carbonyl] indol-1-yl]-2-methylcyclopropyl]-4H-1, 2, 3-triazolo [4, 3-c] pyridine-5-carbonyl] indol-1-yl]-2-methylcyclopropyl]-1, 2, 4-triazolo [4, 3-c] pyridine-5- The invention relates to synthesis of 1, 2, 4-oxadiazole-5-one or a salt thereof, and related synthesis intermediate compounds.

A dry film resist, a photosensitive dry film, and a copper clad laminate. The dry film resist includes an alkali-soluble resin (A), a photopolymerization monomer (B), a photoinitiator (C), and a sensitizer (D); and the sensitizer (D) includes a compound containing a pyrazoline structure.

Methods for treating itch in human patients with atopic dermatitis (AD) and / or prurigo nodularis (PN) comprising administering a therapeutically effective amount of at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3- yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.

The present invention provides a compound having the basic structure shown by Formula (I) in which the indole ring and the pyrazolopyridine structure is bound through a substituent, a salt thereof or a solvate of either the compound or a salt of the compound, as well as a preventative agent or a therapeutic agent for non-insulin-dependent diabetes mellitus (Type 2 diabetes) or obesity containing such compound, salt or solvate as an active ingredient.

The present invention relates to the technical field of pesticides, and in particular to a pyrazole amide compound and a use thereof. The compound is as shown in general formula I, wherein Q represents O or S, W represents CH or N, X represents hydrogen, halogen, alkyl, etc., Y represents halogen or alkyl, Z represents alkyl, alkenyl, alkynyl, cycloalkyl, etc., and M represents hydrogen or alkyl. The compound has good prevention and treatment activity on pests such as green peach aphids, peanut aphids, and bird cherry-oat aphids.

Methods for treating patients with chronic spontaneous urticaria (CSU) comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl) pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.

According to the high-temperature lithium ion battery electrolyte and the lithium ion battery containing the high-temperature lithium ion battery electrolyte, tris (trimethylsilane) phosphate, 2-(3-(trifluoromethyl)-1H-pyrazol-1-yl) acetonitrile and 1, 2, 3-trifluorobenzene are selected as additives in the electrolyte, and the three components can synergistically improve the high-temperature stability of the electrolyte, so that the high-temperature stability of the electrolyte is improved; and gas generated by thermal decomposition and side reaction is reduced, so that the risk that the internal pressure of the battery is abnormally increased or the battery swells due to the gas generated by the electrolyte in the high-temperature long-term storage process is reduced. Meanwhile, the influence of impurities in the electrolyte can be reduced, an electrochemical window is improved, the stability of the electrolyte can be kept at high temperature, and the service life of the battery can be prolonged.

The invention discloses bacillus subtilis LXN-1, and the bacillus subtilis LXN-1 is preserved in the China General Microbiological Culture Collection Center (CGMCC), and the preservation number is CGMCC.NO 31697. The bacillus subtilis LXN-1 is a bacillus subtilis LXN-1 strain. The bacillus subtilis LXN-1 has an inhibition effect on various plant pathogenic bacteria, the inhibition rate on tomato botrytis cinerea can reach 61.5%, the inhibition rate on tobacco brown spot caused by alternaria longibrachiata can reach 72%, the bacillus subtilis LXN-1 also has a virus resistance effect, the inhibition rate on tobacco TMV viral plaque can reach 95%, and the bacillus subtilis LXN-1 has a good application prospect. In addition, the bacillus subtilis LXN-1 also has the potential of being compounded with pesticide bactericides with iprodione, trifloxystrobin, difenoconazole, pyraclostrobin, copper oxychloride and copper hydroxide as main components for use, and has market popularization and application values, and absorption of the plants to nutrient elements can be enhanced, and the growth of the plants can be promoted, and the bacillus subtilis LXN-1 also has the potential of being compounded with the pesticide bactericides with the iprodione, the trifloxystrobin, the difenoconazole, the pyraclostrobin, the copper oxychloride and the copper hydroxide as main components.

Methods for treating immune thrombocytopenia comprising administering at least one compound chosen from (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile (rilzabrutinib) and pharmaceutically acceptable salts thereof are disclosed.

The present invention provides pyrazole-containing fused ring compounds, a pharmaceutical composition thereof and the use thereof. The present invention provides compounds as shown in formula I or pharmaceutically acceptable salts thereof. The compounds are small molecule compounds for non-invasive administration, have the same or similar effect as polypeptide GLP-1 agonists, and have the advantages of one or more of higher biological activity, better metabolic stability and excellent bioavailability.

The invention relates to a preparation method of 1-methyl-5-hydroxypyrazole, which comprises the following steps: (a) methylation reaction: fully dissolving pyrazole in a reaction solvent a, dropwise adding a methylation reagent into the reaction solvent a to carry out methylation reaction, adding water into the reaction solvent a to carry out quenching reaction after the reaction is completed, fully washing and concentrating to generate 1-methylpyrazole; (b) bromination hydrolysis reaction: fully dispersing 1-methylpyrazole in a reaction solvent b, dropwise adding bromine into the reaction solvent b to perform bromination reaction, dropwise adding liquid caustic soda and a sodium thiosulfate solution into the reaction solvent b to perform quenching reaction after the reaction is completed, adding the liquid caustic soda into the reaction solvent b after extraction and concentration, and performing heating hydrolysis and cooling crystallization to obtain the 1-methyl-5-hydroxypyrazole. The preparation method of the 1-methyl-5-hydroxypyrazole is reasonable in design, not only reduces the isomer 1-methyl-3-hydroxypyrazole, but also avoids the use of liquid with pungent smell, such as ethylenediamine, and precursor reagents, such as methylhydrazine, improves the operation safety, is environment-friendly, and is beneficial to industrial production.

The present invention relates to a ternary insecticidal composition of 3-[benzoyl(methyl)amino]-N-[2-bromo-4-(1,1,1,2,3,3,3-heptafluoropropan-2-yl)- 6-(trifluoromethyl)phenyl]-2-fluorobenzamide (Component A), 4-chloro-5-ethyl-2-methyl-N-[[4-(4-methylphenoxy)phenyl]methyl] pyrazole-3-carboxamide (Component B) and at least one insecticide (Component C) demonstrating an effective and synergistic broad spectrum control of insects-pests and mites with one shot application by developing delay in resistance of hard to kill and resistant towards insects-pests and mites Further, the ternary insecticidal composition provides residual control and increases yield of treated plants due to protection against insect-pests and mites. The ternary insecticidal composition of present invention increases overall health and plant vigor and is environmentally safe.

The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and to processes for their preparation, and also to their use for preparing medicaments for the treatment and / or prophylaxis of diseases, in particular cardiovascular and cardiac diseases, preferably heart failure with reduced and preserved ejection fraction (HFrEF, HFmrEF and HFpEF), hypertension (HTN), peripheral arterial diseases (PAD, PAOD), cardio-renal and kidney diseases, preferably chronic and diabetic kidney disease (CKD and DKD), cardiopulmonary and lung diseases, preferable pulmonary hypertension (PH), and other diseases, preferably neurodegenerative diseases and different forms of dementias, fibrotic diseases, systemic sclerosis (SSc), sickle cell disease (SCD), wound healing disorders such as diabetic foot ulcer (DFU).

The present invention relates to an electrochemical process for the synthesis of pyrazolines and pyrazoles of formula (I). The method can be used in particular for the synthesis of the herbicide safener mefenpyr-diethyl. # imgabs0 #

Modified release formulations, such as solid oral dosage forms comprising a core composition comprising Compound (I) and / or a pharmaceutically acceptable salt thereof; a sub-coating layer coating the core composition, said sub-coating layer comprising a polyvinyl alcohol and / or a hydroxypropyl methyl cellulose; and an enteric coating layer encapsulating the sub-coating layer and the core composition, said enteric coating layer comprising at least one polymer selected from an acrylic / methacrylic / ethacrylic acid homopolymer and copolymers thereof, a cellulose derivative, and a polyvinylpyrrolidone, and methods of administration of a Bruton's tyrosine kinase (BTK) inhibitor using said formulations.

The invention discloses a novel methylpyrazole propionamide derivative as well as a preparation method and application thereof. According to the invention, 3-hydroxypyrazole is used as an active matrix skeleton and is combined with a pharmacodynamic group propionamide with herbicidal activity to develop a novel hydroxypyrazole herbicide, and a series of novel 3-oxypropionamide-1-methylpyrazole-carboxylic ester derivatives are designed and synthesized. The invention also provides biological activity of the compounds for controlling agricultural, horticultural and forestry weeds, a determination method of the compounds, and application of the compounds in the fields of agriculture, horticultural and forestry.

The invention discloses a pesticide composition containing a pyrazolecarboxamide pesticide and application of the pesticide composition. The pesticide composition comprises an active component A which is the pyrazolecarboxamide pesticide and a component B which is at least one other pesticide defined in the specification, specifically, the invention relates to a pesticide composition for preventing and treating common lepidoptera, coleoptera, diptera, thysanoptera and homoptera pests of plants.